SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 198.66+0.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: squetch who wrote (7855)9/28/1997 7:45:00 AM
From: Henry Niman   of 32384
 
Stan,My earlier arguement on KS and protease inhibitors was that PI's keep AIDS patients alive long so more will get KS and those that have KS would take treatments longer (like Panretin) because they would live longer (thus a patient with AIDS who developed KS befrore PI's might only live for six months on Panretin because they die of other problems, while post PI's they might live for many years and take Panretin fo quite some time). I really expect the PI impact to diminish however, due to resistant strains.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext